Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates

Visa fullständig post



Permalänk

http://hdl.handle.net/10138/161200

Citation

Boije af Gennäs , G , Talman , V , Yli-Kauhaluoma , J , Tuominen , R K & Ekokoski , E 2011 , ' Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates ' , Current Topics in Medicinal Chemistry , vol. 11 , no. 11 , pp. 1370-1392 .

Titel: Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Författare: Boije af Gennäs, Gustav; Talman, Virpi; Yli-Kauhaluoma, Jari; Tuominen, Raimo K.; Ekokoski, Elina
Upphovmannens organisation: Faculty of Pharmacy
Division of Pharmaceutical Chemistry and Technology
Division of Pharmacology and Pharmacotherapy
Datum: 2011
Språk: eng
Sidantal: 23
Tillhör serie: Current Topics in Medicinal Chemistry
ISSN: 1568-0266
Permanenta länken (URI): http://hdl.handle.net/10138/161200
Abstrakt: The second messenger diacylglycerol (DAG) plays a central role in the signal transduction of G-protein coupled receptors and receptor tyrosine kinases by binding to C1 domain of effector proteins. C1 domain was first identified in protein kinase C (PKC) which comprises a family of ten isoforms that play roles in diverse cellular processes such as proliferation, apoptosis and differentiation. Aberrant signaling through PKC isoforms and other C1 domain-containing proteins has been implicated in several pathological disorders. Drug discovery concerning C1 domains has exploited both natural products and rationally designed compounds. Currently, molecules from several classes of C1 domain-binding compounds are in clinical trials; however, still more have the potential to enter the drug development pipeline. This review gives a summary of the recent developments in C1 domain-binding compounds.
Subject: Protein kinase C
C1 domain
drug discovery
cancer
Alzheimer's disease
bryostatins
ingenol-3-angelate
DAG-lactones
PROTEIN-KINASE-C
CONFORMATIONALLY CONSTRAINED ANALOGS
CHRONIC LYMPHOCYTIC-LEUKEMIA
ACTIVATOR-BINDING DOMAIN
PHORBOL ESTER RECEPTOR
CELLS IN-VITRO
NF-KAPPA-B
NEURONAL ELAV PROTEINS
LACTONES DAG-LACTONES
PROSTATE-CANCER CELLS
317 Pharmacy
Referentgranskad: Ja
Användningsbegränsning: openAccess
Parallelpublicerad version: acceptedVersion


Filer under denna titel

Totalt antal nerladdningar: Laddar...

Filer Storlek Format Granska
Boije_et_al_2011_CurrTopMedChem_POSTPRINT.pdf 1.359Mb PDF Granska/Öppna

Detta dokument registreras i samling:

Visa fullständig post